Secoisolariciresinol diglucoside (SDG) isolated from flaxseed, an alternative to ACE inhibitors in the treatment of hypertension

International Journal of Angiology

Volumn 22, Issue 4, 2013, Pages 235-238

  Prasad, Kailash ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

angiotensin I; angiotensin converting enzyme inhibitor; arterial pressures; flaxseed; secoisolariciresinol diglucoside

Indexed keywords

ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LIGNAN; SECOISOLARICIRESIONOL DIGLUCOSIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BLOOD PRESSURE TRANSDUCER; CAROTID ARTERY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG ISOLATION; DRUG POTENCY; ENZYME INHIBITION; HYPERTENSION; LINSEED; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE;

EID: 84888031131     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0033-1351687     Document Type: Article

References (19)

1. Oomah B. D., Mazza G. Flaxseed proteins: a review. Food Chem: 1993; 48 2 109 114
2. Hettiarachchy N. S., Hareland G. A., Ostenson A., Bladner-Shank G. Chemical composition of 11 flaxseed varieties grown in North Dakota. Proc Flax Institute: 1990; 53 36 50
3. Prasad K., Mantha S. V., Muir A. D., Westcott N. D. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis: 1998; 136 2 367 375
4. Prasad K. Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed. Circulation: 1999; 99 10 1355 1362
5. Westcott N. D., Muir A. D. Process for extracting lignans from flaxseed. US Patent No. 5705618, January 6, 1998
6. Obermeyer W. R., Musser S. M., Betz J. M., Casey R. E., Pohland A. E., Page S. W. Chemical studies of phytoestrogens and related compounds in dietary supplements: flax and chaparral. Proc Soc Exp Biol Med: 1995; 208 1 6 12
7. Washburn S., Burke G. L., Morgan T., Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause: 1999; 6 1 7 13
8. Prasad K. Antihypertensive activity of secoisolariciresinol diglucoside (SDG) isolated from flaxseed: role of guanylate cyclase. Int J Angiol: 2004; 13 7 14
9. Nileeka Balsuriya B. W., Vasantha Rupasinghe H. P. Plant flavonoids as angiotensin converting enzyme inhibitors in regulation of hypertension. Functional Foods Health Disease.: 2011; 1 5 172 188
10. Shimakage A., Shinko M., Yamada S. ACE inhibitory substances derived from soy foods. J Biol Macromol: 2012; 12 3 72 80
11. Gross D. M., Sweet C. S., Ulm E. H., et al. Effect of N-[(S) - 1-carboxy-3-phenylpropyl] - L-Ala-L-Pro and its ethyl ester (MK-421) on angiotensin converting enzyme in vitro and angiotensin I pressure response in vivo. J Pharmacol Exptl Ther.: 1981; 216 3 552 557
12. Muirhead E. F., Prewitt R. L. Jr, Brooks B., Brosius W. L. Jr. Antihypertensive action of the orally active converting enzyme inhibitor (SQ 14, 225) in spontaneously hypertensive rats. Circ Res: 1978; 43 (Suppl. I): 153 159
13. Fregly M. J., Lockley O. E., Simpson S. E. Effect of the angiotensin-converting enzyme inhibitor, captopril, on development of renal hypertension in rats. Pharmacology: 1981; 22 5 277 285
14. Zimmerman B. G., Mommsen C., Kraft E. Renal vasodilatation caused by captopril in conscious normotensive and Goldblatt hypertensive dogs. Proc Soc Exp Biol Med: 1980; 164 4 459 465
15. Alexander J. C., Meyer J. H. Comparison of captopril with placebo in the treatment of essential hypertension. In: Horovitz Z. P., ed. Angiotensin Converting Enzyme Inhibitors, Mechanisms of Action And Clinical Implications. Baltimore and Munich Urban and Schwarzenberg: 1981; 379 392
16. Edgar L., Hogg A., Scott M., et al. ACE inhibitors for the treatment of hypertension drug selection by means of the SOJA method. Rev Recent Clin Trials: 2011; 6 1 69 93
17. Canter D., Frank G. ACE inhibitors in the treatment of hypertension in the older patient. Eur Heart J: 1990; 11 (Suppl D): 33 43
18. Feldman R. ACE inhibitors versus AT1 blockers in the treatment of hypertension and syndrome X. Can J Cardiol: 2000; 16 (Suppl E): 41E 44E
19. Brown N. J., Vaughan D. E. Angiotensin-converting enzyme inhibitors. Circulation: 1998; 97 14 1411 1420